NASDAQ$MASS
908 Devices Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
908 Devices reported Q4 2025 revenue of $19.5M with improved profitability trends.
908 Devices reported Q4 and full-year 2025 results for its handheld mass-spec and forensics platforms, including revenue of about $19.5 million in the quarter and updated 2026 outlook.
- Q4 revenue ~$19.5M.
- Forensics and biopharma analytical instruments.
- Installed base and recurring consumables.
- 2026 outlook provided in release.
- Path to profitability focus.
Headline financials
Revenue & EPS history
908 Devices · Revenue · Quarterly
$19.5M
Forward guidance
2026 guidance on revenue growth and margin improvement from product mix.
Tailwinds
- Niche mass-spec leadership in field applications.
- Consumables annuity from installed base.
- Government and lab end-market diversity.
Headwinds
- Small scale limits operating leverage.
- Lumpy instrument capital sales.
- R&D spend for product extensions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
+1.3%
Avg return
Earnings day
-2.9%
Avg return
5 days after
+2.8%
Avg return
30 days after
46%
11 / 24 earnings
Positive
+96.0%
Q4 2024
Best reaction
-35.4%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +13.7% | +11.8% | +11.8% | |
| Q4 2025 | -4.8% | -5.3% | +0.0% | |
| Q3 2025 | -13.2% | -25.7% | -10.8% | |
| Q1 2025 | -18.9% | -20.1% | +25.5% | |
| Q4 2024 | +96.0% | +39.4% | +88.9% | |
| Q3 2024 | -35.4% | -34.0% | -41.4% | |
| Q2 2024 | -5.0% | -6.0% | -21.6% | |
| Q1 2024 | -1.4% | -1.8% | +7.0% | |
| Q4 2023 | -1.1% | -5.1% | -10.1% | |
| Q3 2023 | -4.9% | -11.2% | +23.0% | |
| Q2 2023 | +17.7% | +15.0% | +8.1% | |
| Q1 2023 | +8.4% | +4.8% | +28.6% | |
| Q4 2022 | +0.3% | -10.6% | -5.5% | |
| Q3 2022 | -34.4% | -38.2% | -44.4% | |
| Q2 2022 | -8.9% | -9.9% | -7.6% | |
| Q1 2022 | -12.6% | +6.6% | -5.5% | |
| Q4 2021 | +12.8% | +17.2% | +24.7% | |
| Q3 2021 | +14.7% | +2.7% | -30.0% | |
| Q3 2020 | +14.7% | +2.7% | -30.0% | |
| Q2 2021 | +9.4% | +5.4% | +26.2% | |
| Q2 2020 | +9.4% | +5.4% | +26.2% | |
| Q1 2021 | -16.3% | -14.6% | -7.3% | |
| Q1 2020 | -16.3% | -14.6% | -7.3% | |
| Q4 2020 | +7.8% | +15.8% | +18.0% | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro